Bradley Campbell – Biography
Last update: April 3, 2026Executive profile
Bradley was Business Director, Cardiovascular at Genzyme, and Manager, Strategy and Operations at Bristol-Myers Squibb. Bradley Campbell joined Biomarin Pharmaceutical in 2006. Bradley served as President and Chief Operating Officer at Biomarin Pharmaceutical.
Bradley Campbell is currentlyPresident and Chief Executive Officer at Amicus Therapeutics - View - Amicus Therapeutics org chart
Create your alert
to follow the career of Bradley Campbell.
Education
Bradley Campbell has a BA Public Policy Studies from Duke University and a Master of Business Administration from Harvard Business School.
They have also studied at Duke University :
Find more alumni from Duke University
They have also studied at Harvard Business School :
Find more alumni from Harvard Business School
More about Bradley Campbell
Selected links
Do you need to know more about Bradley Campbell? More results.
Participate
Social media
- Bradley Campbell on Google News, X (Twitter), LinkedIn, YouTube
- View the pictures of Bradley Campbell
The colleagues of Bradley Campbell
Company Colleagues
- At Amicus Therapeutics, Bradley Campbell has 29 colleagues including Margaret McGlynn (Director), Glenn Sblendorio (Director)…
Industry Colleagues
- In the Biotechnology industry, Bradley Campbell has 35,756 colleagues in 2,406 companies located in 42 countries. 16,877 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.
Report an error
Update the org chart details of Bradley Campbell.
Get in Touch
Here are a few tips for establishing great contacts.
